ACCREDITATION

CME Credits

Accreditation StatementThis activity is approved for 15.5 total AMA PRA Category 1 Credit(s)

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Venkatesh Ramaiah, MD. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians.

The CMEsolutions designates this live activity for a maximum of 15.5 AMA PRA Category 1 CreditsPhysicians should claim only the credit commensurate with the extent of their participation in the activity. 

The target audience is cardiovascular, vascular, and endovascular physicians, allied practitioners, nurses, techs, fellows, residents, students, and industry. 

Faculty Disclosure

CME Solutions, LLC has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Integrity and Independence requiring mitigation of all faculty conflicts of interest. Faculty declaring a relevant financial relationship will be identified in the activity CME information.

American Board of Surgery (ABS) MOC 

Successful completion of this CME activity enables the learner to earn credit toward the CME requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Credit will be reported within 30 days of claiming credit.

All Faculty must complete the following CME Disclosure Form.

 Learning Objectives

    • Evaluate the indications and risks of peripheral vascular disease and critical limb ischemia.

 

    • Identify a treatment option algorithm and address complications of peripheral vascular disease and critical limb ischemia.

 

    • Interpret biomarkers, genome, and genetic determinants of patients with cardiovascular disease

 

    • Demonstrate appropriate pharmacologic management in the care of patients with cardiovascular disease.

 

    • Define the basic principles and management of venous disease and foot ulcers.

 

    • Identify the indications, risks, treatment options, and complications of arch, descending, thoracoabdominal and abdominal aneurysms and dissections.

 

    • Recognize the current treatment options and management of acute/chronic, symptomatic/asymptomatic, and complicated/uncomplicated aortic disease.

 

    • Analyze the latest trials for aortic, peripheral vascular disease venous and foot ulcers.

 

    • Formulate a treatment algorithm for carotid disease.

 

    • Discuss the pros and cons of new and established strategies for acute and chronic DVT treatment, what still works, what might work and what doesn’t work based on evidence.